| Ausstehende Aktien | 11,610,371 shares |
| Insider-Aktien | 3.533.884 shares |
| Insider-Besitz | 30,44 % |
| Insider gesamt | 28 |
Insider-Stimmungswert
Der Insider-Stimmungswert ermittelt die Unternehmen, die von Unternehmensinsidern gekauft werden.
Es ist das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Insiderakkumulation identifiziert. Das Scoring-Modell verwendet eine Kombination aus der Nettozahl der Insiderkäufe der letzten 90 Tage, der Gesamtzahl der gekauften Aktien als Prozentsatz des Streubesitzes und der Gesamtzahl der von Insidern gehaltenen Aktien. Die Zahl reicht von 0 bis 100, wobei höhere Zahlen ein höheres Maß an Insiderkäufen anzeigen als bei anderen Unternehmen und 50 den Durchschnitt darstellt.
Aktualisierungshäufigkeit: Täglich
Führungskräfte-Stimmungswert
Der Führungskräfte-Stimmungswert findet Unternehmen, die von Führungskräften des Unternehmens gekauft werden.
Per Definition sind Führungskräfte des Unternehmens Insider, aber im Gegensatz zu anderen Insidern (10%ige Aktionäre und Vorstandsmitglieder) arbeiten Führungskräfte täglich für das Unternehmen und verwenden beim Handel ihr eigenes Geld. (10%ige Aktionäre und Vorstandsmitglieder sind oft Fondsmanager, die das Geld anderer Leute verwalten.) Daher sind Insider-Geschäfte, die von Führungskräften getätigt werden, viel bedeutender und sollten entsprechend behandelt werden.
Wie der Insider-Stimmungswert ist auch der Führungskräfte-Stimmungswert das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Führungskräftekonzentration identifiziert.
Aktualisierungshäufigkeit: Täglich
Wichtige Insider-Kennzahlen
Diese Karte zeigt, wie das Unternehmen bei verschiedenen Insider-Kennzahlen abschneidet. Der Perzentil-Rang zeigt, wie dieses Unternehmen im Vergleich zu anderen Unternehmen auf den US-Märkten abschneidet. Höhere Ränge deuten auf eine bessere Situation hin.
Es ist beispielsweise allgemein anerkannt, dass Insiderkäufe ein positiver Indikator sind, so dass Unternehmen mit mehr Insiderkäufen besser abschneiden würden als Unternehmen mit weniger Insiderkäufen (oder sogar Insiderverkäufen).
Prozent des Streubesitzes von Insidern gekauft (Rang)
61 out of 10786
Prozent des von Insidern gekauften Streubesitzes ist die Gesamtzahl der von Insidern gekauften Aktien abzüglich der Gesamtzahl der von Insidern in den letzten 90 Tagen verkauften Aktien, geteilt durch den gesamten Streubesitz und multipliziert mit 100.
Diagramm zum Insiderhandel
Surrozen, Inc. Insider-Trades sind in der folgenden Grafik dargestellt. Insider sind leitende Angestellte, Direktoren oder bedeutende Investoren in einem Unternehmen. Im Allgemeinen ist es für Insider illegal, auf der Grundlage von wesentlichen, nicht-öffentlichen Informationen mit Aktien ihrer Unternehmen zu handeln. Das bedeutet nicht, dass es für sie illegal ist, irgendwelche Geschäfte in ihren eigenen Unternehmen zu tätigen. Sie müssen jedoch alle Geschäfte der SEC über ein Formular 4 melden.
Kennzahlen zu Insiderlisten und Rentabilität
Diese Tabelle zeigt die Liste der bekannten Insider und wird automatisch aus den bei der SEC eingereichten Unterlagen erstellt. Zusätzlich zu den Namen, dem letzten Titel und der Bezeichnung als Direktor, leitender Angestellter oder 10%-iger Anteilseigner geben wir die zuletzt veröffentlichten Bestände an. Zusätzlich stellen wir, wenn möglich, die historische Handelsperformance für den Insider zur Verfügung. Die historische Handelsperformance ist ein gewichteter Durchschnitt der Performance tatsächlicher offener Kauftransaktionen, die von dem Insider getätigt wurden. Weitere Informationen zur Berechnung dieses Wertes finden Sie in diesem YouTube-Webinar.
See our leaderboard of most profitable insider traders.
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|---|---|---|
|
Mitchell J Md Blutt
10% Owner -
|
0 | 0 | |
| Anna Berkenblit Director - [D] | 35.129 | 2.342 | |
| Christopher Y Chai Director - [D] | 35.129 | 2.342 | |
|
Column Group Iii Gp, Lp
10% Owner -
|
1.361.485 | 1.361.485 | |
|
Column Group Iii, Lp
10% Owner -
|
4.904.884 | 1.361.485 | |
|
Column Group Iii-a, Lp
10% Owner -
|
4.904.884 | 1.361.485 | |
|
Consonance Capital Management LP
Director, 10% Owner -
[D]
|
450.828 | 0 | |
| Consonance Capital Opportunity Fund Management LP Director - [D] | 0 | 128.900 | |
| Consonance Capman GP, LLC Director - [D] | 450.828 | 0 |
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|---|---|---|
|
Consonance Life Sciences
10% Owner -
|
1.885.000 | 0 | |
| Mary Haak-Frendscho Director - [D] | 35.129 | 2.342 | |
| Christopher Haqq - | 30.000 | 2.000 | |
| Joshua Cory House | 0 | ||
| Jennifer Jarrett - | 30.000 | 2.000 | |
|
Tim Kutzkey
Director, 10% Owner -
[D]
|
1.361.485 | 1.361.485 | |
| Yang Li Exec. Vice President, Research - [O] | 17.216 | 17.216 | |
| Shao-Lee Lin Director - [D] | 35.129 | 2.342 | |
|
Kevin Harold Livingston
10% Owner -
|
1.885.000 | 0 |
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|---|---|---|
| Craig C Parker Chief Executive Officer, Director - [D] [O] | 16.553 | 16.553 | |
| Mace Rothenberg Director - [D] | 35.129 | 2.342 | |
| Donald J Santel - | 30.000 | 2.000 | |
|
Benny Soffer
10% Owner -
|
1.885.000 | 0 | |
| Gad Soffer | 0 | ||
|
TCG Crossover GP II, LLC
10% Owner -
|
736.547 | 736.547 | |
| Geertrui Vanhove Chief Medical Officer - [O] | 32.412 | 2.161 | |
| David J Woodhouse Director - [D] | 35.129 | 2.342 | |
| Charles O Williams Chief Operating Officer - [O] | 16.571 | 16.571 | |
| Wen-Chen Yeh Chief Scientific Officer - [O] | 27.216 | 1.814 |
Report errors via our new Insider Auditing Tool
Erfolgsbilanz der Insiderkäufe - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in SRZN / Surrozen, Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Erfolgsbilanz von Insiderverkäufen - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in SRZN / Surrozen, Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Transaktionshistorie
Klicken Sie auf das Link-Symbol, um den vollständigen Transaktionsverlauf anzuzeigen. Transaktionen, die im Rahmen eines automatischen Handelsplans 10b5-1 gemeldet werden, sind in der Spalte 10b-5 mit einem X gekennzeichnet.
| Datei Datum |
Handel Datum |
Form | Insider | Ticker | Wertpapier-Titel | Code | Direkt | Ausführung Preis |
Einheit Preis |
Eimheiten Verändert |
Wert Geändert (1K) |
Verbleibende Optionen |
Verbleibende Aktien |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-05 | 2026-05-04 | 4 | Li Yang | SRZN | Common Stock | D | 33,3328 | -1.584 | -53 | 17.216 | ||||
| 2026-05-05 | 2026-05-01 | 4 | Li Yang | SRZN | Common Stock | D | 4.375 | 18.800 | ||||||
| 2026-05-05 | 2026-05-04 | 4 | Williams Charles O | SRZN | Common Stock | D | 33,3328 | -2.036 | -68 | 16.571 | ||||
| 2026-05-05 | 2026-05-01 | 4 | Williams Charles O | SRZN | Common Stock | D | 5.625 | 18.607 | ||||||
| 2026-05-05 | 2026-05-04 | 4 | Parker Craig C | SRZN | Common Stock | D | 33,3328 | -4.524 | -151 | 16.553 | ||||
| 2026-05-05 | 2026-05-01 | 4 | Parker Craig C | SRZN | Common Stock | D | 12.500 | 21.077 | ||||||
| 2026-04-01 | 2026-03-31 | 4 | Li Yang | SRZN | Common Stock | D | -1.666 | 14.425 | ||||||
| 2026-03-25 | 2026-03-24 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 24,6931 | 53.329 | 1.317 | 736.547 | ||||
| 2026-03-25 | 2026-03-24 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 24,6931 | 53.329 | 1.317 | 736.554 | ||||
| 2026-03-25 | 2026-03-23 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 24,8999 | 7.611 | 190 | 683.218 | ||||
| 2026-03-25 | 2026-03-23 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 24,8999 | 7.612 | 190 | 683.225 | ||||
| 2026-03-16 | 2026-03-16 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 24,9857 | 595 | 15 | 675.610 | ||||
| 2026-03-16 | 2026-03-16 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 24,9857 | 595 | 15 | 675.613 | ||||
| 2026-03-16 | 2026-03-13 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 24,8769 | 17.716 | 441 | 675.015 | ||||
| 2026-03-16 | 2026-03-13 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 24,8769 | 17.717 | 441 | 675.018 | ||||
| 2026-03-16 | 2026-03-12 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 24,9851 | 6.187 | 155 | 657.299 | ||||
| 2026-03-16 | 2026-03-12 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 24,9851 | 6.187 | 155 | 657.301 | ||||
| 2026-02-13 | 2026-02-12 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 23,8625 | 546 | 13 | 651.112 | ||||
| 2026-02-13 | 2026-02-12 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 23,8625 | 547 | 13 | 651.114 | ||||
| 2026-02-13 | 2026-02-11 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 23,5750 | 8.881 | 209 | 650.563 | ||||
| 2026-02-13 | 2026-02-11 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 23,5750 | 8.882 | 209 | 650.567 | ||||
| 2026-02-03 | 2026-02-03 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 21,9400 | 2.177 | 48 | 641.682 | ||||
| 2026-02-03 | 2026-02-03 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 21,9400 | 2.178 | 48 | 641.685 | ||||
| 2026-02-03 | 2026-02-02 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 21,3800 | 365 | 8 | 639.505 | ||||
| 2026-02-03 | 2026-02-02 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 21,3800 | 366 | 8 | 639.507 | ||||
| 2026-02-03 | 2026-01-30 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 21,3900 | 2.135 | 46 | 639.140 | ||||
| 2026-02-03 | 2026-01-30 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 21,3900 | 2.136 | 46 | 639.141 | ||||
| 2026-01-28 | 3 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 637.005 | ||||||||
| 2026-01-28 | 3 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 637.005 | ||||||||
| 2026-01-20 | 2026-01-20 | 4 | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 19,5999 | 9.568 | 188 | 1.016.658 | ||||
| 2026-01-20 | 2026-01-20 | 4 | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 19,5999 | 8.484 | 166 | 900.292 | ||||
| 2026-01-20 | 2026-01-16 | 4 | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 20,0000 | 1.358 | 27 | 1.007.090 | ||||
| 2026-01-20 | 2026-01-16 | 4 | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 20,0000 | 1.204 | 24 | 891.808 | ||||
| 2026-01-20 | 2026-01-15 | 4 | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 19,8890 | 6.303 | 125 | 1.005.732 | ||||
| 2026-01-20 | 2026-01-15 | 4 | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 19,8890 | 5.590 | 111 | 890.604 | ||||
| 2026-01-20 | 2026-01-20 | 4 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 19,5999 | 9.568 | 188 | 1.016.658 | ||||
| 2026-01-20 | 2026-01-20 | 4 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 19,5999 | 8.484 | 166 | 900.292 | ||||
| 2026-01-20 | 2026-01-16 | 4 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 20,0000 | 1.358 | 27 | 1.007.090 | ||||
| 2026-01-20 | 2026-01-16 | 4 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 20,0000 | 1.204 | 24 | 891.808 | ||||
| 2026-01-20 | 2026-01-15 | 4 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 19,8890 | 6.303 | 125 | 1.005.732 | ||||
| 2026-01-20 | 2026-01-15 | 4 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 19,8890 | 5.590 | 111 | 890.604 | ||||
| 2026-01-15 | 2026-01-14 | 4 | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 19,9883 | 2.927 | 59 | 999.429 | ||||
| 2026-01-15 | 2026-01-14 | 4 | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 19,9883 | 2.596 | 52 | 885.014 | ||||
| 2026-01-15 | 2026-01-13 | 4 | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 19,8041 | 6.609 | 131 | 996.502 | ||||
| 2026-01-15 | 2026-01-13 | 4 | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 19,8041 | 5.861 | 116 | 882.418 | ||||
| 2026-01-15 | 2026-01-14 | 4 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 19,9883 | 2.927 | 59 | 999.429 | ||||
| 2026-01-15 | 2026-01-14 | 4 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 19,9883 | 2.596 | 52 | 885.014 | ||||
| 2026-01-15 | 2026-01-13 | 4 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 19,8041 | 6.609 | 131 | 996.502 | ||||
| 2026-01-15 | 2026-01-13 | 4 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 19,8041 | 5.861 | 116 | 882.418 | ||||
| 2026-01-08 | 2026-01-06 | 4 | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 19,8872 | 8.003 | 159 | 989.893 | ||||
| 2026-01-08 | 2026-01-06 | 4 | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 19,8872 | 7.097 | 141 | 876.557 | ||||
| 2026-01-08 | 2026-01-06 | 4 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 19,8872 | 8.003 | 159 | 989.893 | ||||
| 2026-01-08 | 2026-01-06 | 4 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 19,8872 | 7.097 | 141 | 876.557 | ||||
| 2026-01-06 | 2026-01-05 | 4 | Li Yang | SRZN | Common Stock | D | 19,8652 | -1.118 | -22 | 16.091 | ||||
| 2026-01-06 | 2026-01-02 | 4 | Li Yang | SRZN | Common Stock | D | 2.500 | 17.209 | ||||||
| 2026-01-06 | 2026-01-05 | 4 | Williams Charles O | SRZN | Common Stock | D | 19,8652 | -1.566 | -31 | 12.982 | ||||
| 2026-01-06 | 2026-01-02 | 4 | Williams Charles O | SRZN | Common Stock | D | 3.500 | 14.548 | ||||||
| 2025-12-16 | 2025-12-15 | 4 | Li Yang | SRZN | Common Stock | D | 8,1100 | 1.666 | 14 | 14.709 | ||||
| 2025-12-16 | 2025-12-15 | 4 | Williams Charles O | SRZN | Common Stock | D | 8,1100 | 1.666 | 14 | 11.048 | ||||
| 2025-12-16 | 2025-12-15 | 4 | Parker Craig C | SRZN | Common Stock | D | 8,1100 | 1.553 | 13 | 8.577 | ||||
| 2025-12-08 | 2025-12-05 | 4 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 19,5409 | 16.381 | 320 | 981.890 | ||||
| 2025-12-08 | 2025-12-05 | 4 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 19,5409 | 14.503 | 283 | 869.460 | ||||
| 2025-12-08 | 2025-12-04 | 4 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 17,3470 | 2.791 | 48 | 965.509 | ||||
| 2025-12-08 | 2025-12-04 | 4 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 17,3470 | 2.475 | 43 | 854.957 | ||||
| 2025-12-08 | 2025-12-05 | 4 | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 19,5409 | 16.381 | 320 | 981.890 | ||||
| 2025-12-08 | 2025-12-05 | 4 | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 19,5409 | 14.503 | 283 | 869.460 | ||||
| 2025-12-08 | 2025-12-04 | 4 | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 17,3470 | 2.791 | 48 | 965.509 | ||||
| 2025-12-08 | 2025-12-04 | 4 | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 17,3470 | 2.475 | 43 | 854.957 | ||||
| 2025-12-02 | 2025-11-13 | 4 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 12,6500 | 167.307 | 2.116 | 962.718 | ||||
| 2025-12-02 | 2025-11-13 | 4 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 12,6500 | 148.150 | 1.874 | 852.482 | ||||
| 2025-11-17 | 2025-11-13 | 4 | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 12,6500 | 167.307 | 2.116 | 962.718 | ||||
| 2025-11-17 | 2025-11-13 | 4 | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 12,6500 | 148.150 | 1.874 | 852.482 | ||||
| 2025-06-16 | 2025-06-13 | 4 | Li Yang | SRZN | Common Stock | D | 8,0600 | 400 | 3 | 13.043 | ||||
| 2025-06-16 | 2025-06-13 | 4 | Williams Charles O | SRZN | Common Stock | D | 8,0600 | 400 | 3 | 9.382 | ||||
| 2025-06-16 | 2025-06-13 | 4 | Parker Craig C | SRZN | Common Stock | D | 8,0600 | 400 | 3 | 7.024 | ||||
| 2025-03-28 | 3 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 795.411 | ||||||||
| 2025-03-28 | 3 | Kutzkey Tim By The Column Group Opportunity III, LP | SRZN | Common Stock | I | 344.827 | ||||||||
| 2025-03-28 | 3 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 704.332 | ||||||||
| 2025-03-28 | 2025-03-26 | 4 | COLUMN GROUP III GP, LP By The Column Group Opportunity III, LP | SRZN | Common Stock | I | 11,6000 | 344.827 | 4.000 | 344.827 | ||||
| 2025-03-28 | 2025-03-26 | 4 | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 11,6000 | 365.769 | 4.243 | 795.411 | ||||
| 2025-03-28 | 2025-03-26 | 4 | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 11,6000 | 323.886 | 3.757 | 704.332 | ||||
| 2025-01-06 | 2025-01-03 | 4 | Li Yang | SRZN | Common Stock | D | 17,3700 | -843 | -15 | 13.345 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Li Yang | SRZN | Common Stock | D | 2.500 | 14.188 | ||||||
| 2025-01-06 | 2025-01-03 | 4 | Williams Charles O | SRZN | Common Stock | D | 17,3700 | -1.181 | -21 | 8.982 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Williams Charles O | SRZN | Common Stock | D | 3.500 | 10.163 | ||||||
| 2024-06-18 | 2024-06-14 | 4 | Li Yang | SRZN | Common Stock | D | 5,6700 | 400 | 2 | 10.888 | ||||
| 2024-06-18 | 2024-06-14 | 4 | Williams Charles O | SRZN | Common Stock | D | 5,6700 | 400 | 2 | 5.863 | ||||
| 2024-06-18 | 2024-06-14 | 4 | Parker Craig C | SRZN | Common Stock | D | 5,6700 | 400 | 2 | 5.824 | ||||
| 2024-04-17 | 2024-04-04 | 4/A | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 15,5000 | 102.651 | 1.591 | 326.992 | ||||
| 2024-04-17 | 2024-04-04 | 4/A | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 15,5000 | 90.897 | 1.409 | 289.549 | ||||
| 2024-04-17 | 2024-04-04 | 4/A | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 15,5000 | 102.651 | 1.591 | 326.992 | ||||
| 2024-04-17 | 2024-04-04 | 4/A | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 15,5000 | 90.897 | 1.409 | 289.549 | ||||
| 2024-04-08 | 2024-04-04 | 4 | Williams Charles O | SRZN | Common Stock | D | 1.474 | 1.474 | ||||||
| 2024-04-08 | 2024-04-04 | 4 | Parker Craig C | SRZN | Common Stock | D | 1.474 | 1.474 | ||||||
| 2024-04-08 | 2024-04-04 | 4 | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 15,5000 | 102.651 | 1.591 | 332.885 | ||||
| 2024-04-08 | 2024-04-04 | 4 | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 15,5000 | 90.897 | 1.409 | 294.767 | ||||
| 2024-04-08 | 2024-04-04 | 4 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 15,5000 | 102.651 | 1.591 | 332.885 | ||||
| 2024-04-08 | 2024-04-04 | 4 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 15,5000 | 90.897 | 1.409 | 294.767 | ||||
| 2023-12-18 | 2023-12-15 | 4 | Williams Charles O | SRZN | Common Stock | D | 5,6700 | 2.085 | 12 | 2.085 | ||||
| 2023-12-18 | 2023-12-15 | 4 | Li Yang | SRZN | Common Stock | D | 5,6700 | 2.085 | 12 | 2.085 | ||||
| 2023-12-18 | 2023-12-15 | 4 | Parker Craig C | SRZN | Common Stock | D | 5,6700 | 2.046 | 12 | 2.046 | ||||
| 2023-08-23 | 3 | Li Yang | SRZN | Common Stock | I | 10.538 | ||||||||
| 2023-08-23 | 3 | Li Yang | SRZN | Common Stock | D | 121.524 | ||||||||
| 2023-06-20 | 2023-06-15 | 4 | Yeh Wen-Chen | SRZN | Common Stock | D | 0,3800 | 17.638 | 7 | 27.216 | ||||
| 2023-06-20 | 2023-06-15 | 4 | Parker Craig C | SRZN | Common Stock | D | 0,3800 | 25.000 | 10 | 34.578 | ||||
| 2023-06-20 | 2023-06-15 | 4 | Williams Charles O | SRZN | Common Stock | D | 0,3800 | 25.000 | 10 | 34.578 | ||||
| 2022-12-19 | 2022-12-15 | 4 | Yeh Wen-Chen | SRZN | Common Stock | D | 0,4100 | 9.578 | 4 | 229.138 | ||||
| 2022-12-19 | 2022-12-15 | 4 | Parker Craig C | SRZN | Common Stock | D | 0,4100 | 9.578 | 4 | 9.578 | ||||
| 2022-12-19 | 2022-12-15 | 4 | Vanhove Geertrui | SRZN | Common Stock | D | 0,4100 | 9.578 | 4 | 32.412 | ||||
| 2022-12-19 | 2022-12-15 | 4 | Williams Charles O | SRZN | Common Stock | D | 0,4100 | 9.578 | 4 | 9.578 | ||||
| 2022-12-15 | 2022-12-14 | 4 | BLUTT MITCHELL J MD By Consonance Life Sciences, LLC | SRZN | Common Stock | I | -1.885.000 | 0 | ||||||
| 2022-12-15 | 2022-12-14 | 4 | BLUTT MITCHELL J MD By Managed Account | SRZN | Common Stock | I | -450.827 | 0 | ||||||
| 2022-12-15 | 2022-12-14 | 4 | BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP | SRZN | Common Stock | I | -1.297.922 | 0 | ||||||
| 2022-12-15 | 2022-12-14 | 4 | BLUTT MITCHELL J MD By Consonance Capital Master Account LP | SRZN | Common Stock | I | -1.748.750 | 0 | ||||||
| 2022-03-03 | 2022-03-01 | 4 | Yeh Wen-Chen | SRZN | Option (right to buy) | D | 3,11 | 125.000 | 125.000 | |||||
| 2022-03-03 | 2022-03-01 | 4 | Parker Craig C | SRZN | Stock Option (right to buy) | D | 3,11 | 370.000 | 370.000 | |||||
| 2022-03-03 | 2022-03-01 | 4 | Williams Charles O | SRZN | Option (right to buy) | D | 3,11 | 125.000 | 125.000 | |||||
| 2022-03-03 | 2022-03-01 | 4 | Vanhove Geertrui | SRZN | Option Grant (right to buy) | D | 3,11 | 3,1100 | 125.000 | 389 | 125.000 | |||
| 2021-08-16 | 3 | COLUMN GROUP III, LP By The Column Group III, LP | SRZN | Common Stock | I | 4.343.245 | ||||||||
| 2021-08-16 | 3 | COLUMN GROUP III, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 4.904.884 | ||||||||
| 2021-08-16 | 3 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 4.343.245 | ||||||||
| 2021-08-16 | 3 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 4.904.884 | ||||||||
| 2021-08-16 | 2021-08-12 | 4 | Parker Craig C | SRZN | Stock Option (right to buy) | D | 10,25 | 183.335 | 183.335 | |||||
| 2021-08-16 | 2021-08-12 | 4 | Vanhove Geertrui | SRZN | Employee Stock Option (right to buy) | D | 10,25 | 36.647 | 36.647 | |||||
| 2021-08-16 | 3 | Vanhove Geertrui | SRZN | Common Stock | D | 22.834 | ||||||||
| 2021-08-16 | 2021-08-12 | 4 | Williams Charles O | SRZN | Employee Stock Option (right to buy) | D | 10,25 | 14.597 | 14.597 | |||||
| 2021-08-16 | 3 | WOODHOUSE DAVID J | SRZN | Common Stock | D | 35.129 | ||||||||
| 2021-08-16 | 3 | Rothenberg Mace | SRZN | Common Stock | D | 35.129 | ||||||||
| 2021-08-16 | 3 | Haak-Frendscho Mary | SRZN | Common Stock | D | 35.129 | ||||||||
| 2021-08-16 | 3 | Berkenblit Anna | SRZN | Common Stock | D | 35.129 | ||||||||
| 2021-08-16 | 3 | Lin Shao-Lee | SRZN | Common Stock | D | 35.129 | ||||||||
| 2021-08-16 | 3 | Yeh Wen-Chen | SRZN | Common Stock | D | 219.560 | ||||||||
| 2021-08-16 | 3 | CHAI CHRISTOPHER Y | SRZN | Common Stock | D | 35.129 | ||||||||
| 2021-08-13 | 2021-08-11 | 4 | Consonance Life Sciences | SRZN | Warrants | I | 11,50 | -144.667 | 144.667 | |||||
| 2021-08-13 | 2021-08-11 | 4 | Consonance Life Sciences | SRZN | Warrants | I | 11,50 | -144.667 | 0 | |||||
| 2021-08-13 | 2021-08-11 | 4 | Consonance Life Sciences | SRZN | Common Stock | I | 1.451.000 | 1.885.000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Consonance Life Sciences | SRZN | Common Stock | I | 434.000 | 434.000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Consonance Life Sciences | SRZN | Class B Ordinary Shares | I | -1.451.000 | 0 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Consonance Life Sciences | SRZN | Class B Ordinary Shares | I | -759.000 | 1.451.000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Consonance Life Sciences | SRZN | Class A Ordinary Shares | I | -434.000 | 0 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Jarrett Jennifer | SRZN | Class B Ordinary Shares | D | -30.000 | 0 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Jarrett Jennifer | SRZN | Common Stock | D | 30.000 | 30.000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Santel Donald J | SRZN | Class B Ordinary Shares | D | -30.000 | 0 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Santel Donald J | SRZN | Common Stock | D | 30.000 | 30.000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Soffer Benny | SRZN | Warrants | I | 11,50 | -144.667 | 144.667 | |||||
| 2021-08-13 | 2021-08-11 | 4 | Soffer Benny | SRZN | Warrants | I | 11,50 | -144.667 | 0 | |||||
| 2021-08-13 | 2021-08-11 | 4 | Soffer Benny | SRZN | Common Stock | I | 1.451.000 | 1.885.000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Soffer Benny | SRZN | Common Stock | I | 434.000 | 434.000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Soffer Benny | SRZN | Class B Ordinary Shares | I | -1.451.000 | 0 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Soffer Benny | SRZN | Class B Ordinary Shares | I | -759.000 | 1.451.000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Soffer Benny | SRZN | Class A Ordinary Shares | I | -434.000 | 0 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Haqq Christopher | SRZN | Class B Ordinary Shares | D | -30.000 | 0 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Haqq Christopher | SRZN | Common Stock | D | 30.000 | 30.000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Livingston Kevin Harold | SRZN | Warrants | I | 11,50 | -144.667 | 144.667 | |||||
| 2021-08-13 | 2021-08-11 | 4 | Livingston Kevin Harold | SRZN | Warrants | I | 11,50 | -144.667 | 0 | |||||
| 2021-08-13 | 2021-08-11 | 4 | Livingston Kevin Harold | SRZN | Common Stock | I | 1.451.000 | 1.885.000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Livingston Kevin Harold | SRZN | Common Stock | I | 434.000 | 434.000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Livingston Kevin Harold | SRZN | Class B Ordinary Shares | I | -1.451.000 | 0 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Livingston Kevin Harold | SRZN | Class B Ordinary Shares | I | -759.000 | 1.451.000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Livingston Kevin Harold | SRZN | Class A Ordinary Shares | I | -434.000 | 0 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Managed Account | SRZN | Warrants (right to buy) | I | 11,50 | 107.309 | 150.275 | |||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP | SRZN | Warrants (right to buy) | I | 11,50 | 308.940 | 432.640 | |||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Consonance Capital Master Account LP | SRZN | Warrants (right to buy) | I | 11,50 | 416.250 | 582.917 | |||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Managed Account | SRZN | Warrants (right to buy) | I | 11,50 | 42.966 | 42.966 | |||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP | SRZN | Warrants (right to buy) | I | 11,50 | 123.700 | 123.700 | |||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Consonance Capital Master Account LP | SRZN | Warrants (right to buy) | I | 11,50 | 166.667 | 166.667 | |||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Managed Account | SRZN | Common Stock | I | 321.928 | 450.828 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP | SRZN | Common Stock | I | 926.822 | 1.297.922 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Consonance Capital Master Account LP | SRZN | Common Stock | I | 1.248.750 | 1.748.750 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Managed Account | SRZN | Common Stock | I | 128.900 | 128.900 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Managed Account | SRZN | Class A Ordinary Shares | I | -128.900 | 0 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP | SRZN | Common Stock | I | 371.100 | 371.100 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP | SRZN | Class A Ordinary Shares | I | -371.100 | 0 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Consonance Capital Master Account LP | SRZN | Common Stock | I | 500.000 | 500.000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Consonance Capital Master Account LP | SRZN | Class A Ordinary Shares | I | -500.000 | 0 | ||||||
| 2021-05-19 | 2020-11-23 | 4/A | Consonance Life Sciences | CHFW | Warrant | D | 11,50 | 136.667 | 136.667 | |||||
| 2021-05-19 | 2020-11-23 | 4/A | Consonance Life Sciences | CHFW | Class A Ordinary Shares | D | 410.000 | 410.000 | ||||||
| 2021-05-19 | 2020-11-18 | 4/A | Consonance Life Sciences | CHFW | Class B Ordinary Shares | D | 0,0109 | -30.000 | -0 | 2.210.000 | ||||
| 2021-05-19 | 2020-11-18 | 4/A | Consonance Life Sciences | CHFW | Class B Ordinary Shares | D | 0,0109 | -30.000 | -0 | 2.210.000 | ||||
| 2021-05-19 | 2020-11-18 | 4/A | Consonance Life Sciences | CHFW | Class B Ordinary Shares | D | 0,0109 | -30.000 | -0 | 2.240.000 | ||||
| 2021-05-19 | 2020-11-10 | 4/A | Consonance Life Sciences | CHFW | Class B Ordinary Shares | D | -575.000 | 2.300.000 | ||||||
| 2021-05-19 | 2020-10-08 | 4/A | Consonance Life Sciences | CHFW | Class B Ordinary Shares | D | -718.750 | 2.875.000 | ||||||
| 2021-05-19 | 2020-09-04 | 4/A | Consonance Life Sciences | CHFW | Class B Ordinary Shares | D | 0,0070 | 3.593.750 | 25 | 3.593.750 | ||||
| 2021-05-19 | 2020-12-01 | 4/A | Soffer Benny | CHFW | Warrant | I | 11,50 | 8.000 | 144.667 | |||||
| 2021-05-19 | 2020-12-01 | 4/A | Soffer Benny | CHFW | Class A Ordinary Shares | I | 24.000 | 434.000 | ||||||
| 2021-05-19 | 2020-11-23 | 4/A | BLUTT MITCHELL J MD | CHFW | Warrant | I | 11,50 | 136.667 | 136.667 | |||||
| 2021-05-19 | 2020-11-23 | 4/A | BLUTT MITCHELL J MD | CHFW | Class A Ordinary Shares | I | 410.000 | 410.000 | ||||||
| 2021-05-19 | 2020-11-18 | 4/A | BLUTT MITCHELL J MD | CHFW | Class B Ordinary Shares | I | 0,0109 | -30.000 | -0 | 2.210.000 | ||||
| 2021-05-19 | 2020-11-18 | 4/A | BLUTT MITCHELL J MD | CHFW | Class B Ordinary Shares | I | 0,0109 | -30.000 | -0 | 2.210.000 | ||||
| 2021-05-19 | 2020-11-18 | 4/A | BLUTT MITCHELL J MD | CHFW | Class B Ordinary Shares | I | 0,0109 | -30.000 | -0 | 2.240.000 | ||||
| 2021-05-19 | 2020-11-10 | 4/A | BLUTT MITCHELL J MD | CHFW | Class B Ordinary Shares | I | -575.000 | 2.300.000 | ||||||
| 2021-05-19 | 2020-10-08 | 4/A | BLUTT MITCHELL J MD | CHFW | Class B Ordinary Shares | I | -718.750 | 2.875.000 | ||||||
| 2021-05-19 | 2020-09-04 | 4/A | BLUTT MITCHELL J MD | CHFW | Class B Ordinary Shares | I | 0,0070 | 3.593.750 | 25 | 3.593.750 | ||||
| 2021-05-19 | 2020-11-23 | 4/A | Soffer Benny | CHFW | Warrant | I | 11,50 | 136.667 | 136.667 | |||||
| 2021-05-19 | 2020-11-23 | 4/A | Soffer Benny | CHFW | Class A Ordinary Shares | I | 410.000 | 410.000 | ||||||
| 2021-05-19 | 2020-11-18 | 4/A | Soffer Benny | CHFW | Class B Ordinary Shares | I | 0,0109 | -30.000 | -0 | 2.210.000 | ||||
| 2021-05-19 | 2020-11-18 | 4/A | Soffer Benny | CHFW | Class B Ordinary Shares | I | 0,0109 | -30.000 | -0 | 2.210.000 | ||||
| 2021-05-19 | 2020-11-18 | 4/A | Soffer Benny | CHFW | Class B Ordinary Shares | I | 0,0109 | -30.000 | -0 | 2.240.000 | ||||
| 2021-05-19 | 2020-11-10 | 4/A | Soffer Benny | CHFW | Class B Ordinary Shares | I | -575.000 | 2.300.000 | ||||||
| 2021-05-19 | 2020-10-08 | 4/A | Soffer Benny | CHFW | Class B Ordinary Shares | I | -718.750 | 2.875.000 | ||||||
| 2021-05-19 | 2020-09-04 | 4/A | Soffer Benny | CHFW | Class B Ordinary Shares | I | 0,0070 | 3.593.750 | 25 | 3.593.750 | ||||
| 2021-05-19 | 2020-12-01 | 4/A | Consonance Life Sciences | CHFW | Warrant | D | 11,50 | 8.000 | 144.667 | |||||
| 2021-05-19 | 2020-12-01 | 4/A | Consonance Life Sciences | CHFW | Class A Ordinary Shares | D | 24.000 | 434.000 | ||||||
| 2021-05-19 | 2020-12-01 | 4/A | Livingston Kevin Harold | CHFW | Warrant | I | 11,50 | 8.000 | 144.667 | |||||
| 2021-05-19 | 2020-12-01 | 4/A | Livingston Kevin Harold | CHFW | Class A Ordinary Shares | I | 24.000 | 434.000 | ||||||
| 2021-05-19 | 2020-11-23 | 4/A | Livingston Kevin Harold | CHFW | Warrant | I | 11,50 | 136.667 | 136.667 | |||||
| 2021-05-19 | 2020-11-23 | 4/A | Livingston Kevin Harold | CHFW | Class A Ordinary Shares | I | 410.000 | 410.000 | ||||||
| 2021-05-19 | 2020-11-18 | 4/A | Livingston Kevin Harold | CHFW | Class B Ordinary Shares | I | 0,0109 | -30.000 | -0 | 2.210.000 | ||||
| 2021-05-19 | 2020-11-18 | 4/A | Livingston Kevin Harold | CHFW | Class B Ordinary Shares | I | 0,0109 | -30.000 | -0 | 2.210.000 | ||||
| 2021-05-19 | 2020-11-18 | 4/A | Livingston Kevin Harold | CHFW | Class B Ordinary Shares | I | 0,0109 | -30.000 | -0 | 2.240.000 | ||||
| 2021-05-19 | 2020-11-10 | 4/A | Livingston Kevin Harold | CHFW | Class B Ordinary Shares | I | -575.000 | 2.300.000 | ||||||
| 2021-05-19 | 2020-10-08 | 4/A | Livingston Kevin Harold | CHFW | Class B Ordinary Shares | I | -718.750 | 2.875.000 | ||||||
| 2021-05-19 | 2020-09-04 | 4/A | Livingston Kevin Harold | CHFW | Class B Ordinary Shares | I | 0,0070 | 3.593.750 | 25 | 3.593.750 | ||||
| 2021-05-19 | 2020-12-01 | 4/A | BLUTT MITCHELL J MD | CHFW | Warrant | I | 11,50 | 8.000 | 144.667 | |||||
| 2021-05-19 | 2020-12-01 | 4/A | BLUTT MITCHELL J MD | CHFW | Class A Ordinary Shares | I | 24.000 | 434.000 | ||||||
| 2021-05-19 | 3/A | BLUTT MITCHELL J MD Consonance Life Sciences, LLC | CHFW | Class B Ordinary Shares | I | 2.210.000 | ||||||||
| 2021-05-19 | 3/A | Soffer Benny Consonance Life Sciences, LLC | CHFW | Class B Ordinary Shares | I | 2.210.000 | ||||||||
| 2021-05-19 | 3/A | Livingston Kevin Harold Consonance Life Sciences, LLC | CHFW | Class B Ordinary Shares | I | 2.210.000 | ||||||||
| 2021-05-19 | 3/A | Consonance Life Sciences | CHFW | Class B Ordinary Shares | D | 2.210.000 | ||||||||
| 2020-12-04 | 2020-11-23 | 4 | BLUTT MITCHELL J MD By Managed Account | CHFW | Class A Ordinary Shares | I | 128.900 | 128.900 | ||||||
| 2020-12-04 | 2020-11-23 | 4 | BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP | CHFW | Class A Ordinary Shares | I | 371.100 | 371.100 | ||||||
| 2020-12-04 | 2020-11-23 | 4 | BLUTT MITCHELL J MD By Consonance Capital Master Account, LP | CHFW | Class A Ordinary Shares | I | 500.000 | 500.000 | ||||||
| 2020-12-03 | 2020-12-01 | 4 | Livingston Kevin Harold | CHFW | Warrant | I | 11,50 | 8.000 | 144.667 | |||||
| 2020-12-03 | 2020-12-01 | 4 | Livingston Kevin Harold | CHFW | Class A Ordinary Shares | I | 24.000 | 434.000 | ||||||
| 2020-12-03 | 2020-12-01 | 4 | Consonance Life Sciences | CHFW | Warrant | D | 11,50 | 8.000 | 144.667 | |||||
| 2020-12-03 | 2020-12-01 | 4 | Consonance Life Sciences | CHFW | Class A Ordinary Shares | D | 24.000 | 434.000 | ||||||
| 2020-12-03 | 2020-12-01 | 4 | Soffer Benny | CHFW | Warrant | I | 11,50 | 8.000 | 144.667 | |||||
| 2020-12-03 | 2020-12-01 | 4 | Soffer Benny | CHFW | Class A Ordinary Shares | I | 24.000 | 434.000 | ||||||
| 2020-12-03 | 2020-12-01 | 4 | BLUTT MITCHELL J MD | CHFW | Warrant | I | 11,50 | 8.000 | 144.667 | |||||
| 2020-12-03 | 2020-12-01 | 4 | BLUTT MITCHELL J MD | CHFW | Class A Ordinary Shares | I | 24.000 | 434.000 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Consonance Life Sciences | CHFW | Warrant | D | 11,50 | 136.667 | 136.667 | |||||
| 2020-11-25 | 2020-11-23 | 4 | Consonance Life Sciences | CHFW | Class A Ordinary Shares | D | 410.000 | 410.000 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Soffer Benny | CHFW | Warrant | I | 11,50 | 136.667 | 136.667 | |||||
| 2020-11-25 | 2020-11-23 | 4 | Soffer Benny | CHFW | Class A Ordinary Shares | I | 410.000 | 410.000 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | BLUTT MITCHELL J MD | CHFW | Warrant | I | 11,50 | 136.667 | 136.667 | |||||
| 2020-11-25 | 2020-11-23 | 4 | BLUTT MITCHELL J MD | CHFW | Class A Ordinary Shares | I | 410.000 | 410.000 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Livingston Kevin Harold | CHFW | Warrant | I | 11,50 | 136.667 | 136.667 | |||||
| 2020-11-25 | 2020-11-23 | 4 | Livingston Kevin Harold | CHFW | Class A Ordinary Shares | I | 410.000 | 410.000 |
P
Offener Markt oder privater Kauf von nicht-derivativen oder derivativen Wertpapieren
S
Freiverkauf oder privater Verkauf von nicht-derivativen oder derivativen Wertpapieren
A
Gewährung, Vergabe oder sonstiger Erwerb von Wertpapieren des Unternehmens (z. B. eine Option)
C
Umwandlung von Derivaten
D
Verkauf oder Rückübertragung von Wertpapieren an das Unternehmen
F
Zahlung des Ausübungspreises oder der Steuerschuld mit einem Teil der vom Unternehmen erhaltenen Wertpapiere
G
Schenkung von Wertpapieren durch oder an den Insider
K
Aktien-Swaps und ähnliche Absicherungstransaktionen
M
Ausübung oder Umwandlung eines vom Unternehmen erhaltenen derivativen Wertpapiers (z. B. einer Option)
V
Eine freiwillig auf Formular 4 gemeldete Transaktion
J
Sonstige (mit einer Fußnote zur Beschreibung der Transaktion)
